Supriya Lifescience Ltd has received approval for a capital expenditure of Rs. 60 crores over the next 3 years for the development of a CDMO facility at their Ambernath site.
AI Assistant
Supriya Lifescience Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.